Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

AXL targeting overcomes human lung cancer cell resistance to NK and CTL-mediated cytotoxicity.

Terry S, Abdou A, Engelsen AST, Buart S, Dessen P, Corgnac S, Collares D, Meurice G, Gausdal G, Baud V, Saintigny P, Lorens JB, Thiery JP, Mami-Chouaib F, Chouaib S.

Cancer Immunol Res. 2019 Sep 5. pii: canimm.0903.2019. doi: 10.1158/2326-6066.CIR-18-0903. [Epub ahead of print]

PMID:
31488404
2.

Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.

Terry S, Faouzi Zaarour R, Hassan Venkatesh G, Francis A, El-Sayed W, Buart S, Bravo P, Thiery J, Chouaib S.

Int J Mol Sci. 2018 Oct 6;19(10). pii: E3044. doi: 10.3390/ijms19103044. Review.

3.

Transcriptional response to hypoxic stress in melanoma and prognostic potential of GBE1 and BNIP3.

Buart S, Terry S, Noman MZ, Lanoy E, Boutros C, Fogel P, Dessen P, Meurice G, Gaston-Mathé Y, Vielh P, Roy S, Routier E, Marty V, Ferlicot S, Legrès L, Bouchtaoui ME, Kamsu-Kom N, Muret J, Deutsch E, Eggermont A, Soria JC, Robert C, Chouaib S.

Oncotarget. 2017 Oct 30;8(65):108786-108801. doi: 10.18632/oncotarget.22150. eCollection 2017 Dec 12.

4.

Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.

Francis A, Venkatesh GH, Zaarour RF, Zeinelabdin NA, Nawafleh HH, Prasad P, Buart S, Terry S, Chouaib S.

Crit Rev Immunol. 2018;38(6):505-524. doi: 10.1615/CritRevImmunol.2019030168.

PMID:
31002604
5.

Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity.

Terry S, Buart S, Chouaib S.

Front Immunol. 2017 Nov 24;8:1625. doi: 10.3389/fimmu.2017.01625. eCollection 2017. Review.

6.

Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner.

Mgrditchian T, Arakelian T, Paggetti J, Noman MZ, Viry E, Moussay E, Van Moer K, Kreis S, Guerin C, Buart S, Robert C, Borg C, Vielh P, Chouaib S, Berchem G, Janji B.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9271-E9279. doi: 10.1073/pnas.1703921114. Epub 2017 Oct 16.

7.

Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity.

Terry S, Buart S, Tan TZ, Gros G, Noman MZ, Lorens JB, Mami-Chouaib F, Thiery JP, Chouaib S.

Oncoimmunology. 2017 Jan 17;6(2):e1271858. doi: 10.1080/2162402X.2016.1271858. eCollection 2017.

8.

Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.

Peyvandi S, Buart S, Samah B, Vétizou M, Zhang Y, Durrieu L, Polrot M, Chouaib S, Benihoud K, Louache F, Karray S.

Cancer Res. 2015 Oct 15;75(20):4292-301. doi: 10.1158/0008-5472.CAN-14-1848. Epub 2015 Sep 10.

9.

Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.

Noman MZ, Buart S, Romero P, Ketari S, Janji B, Mari B, Mami-Chouaib F, Chouaib S.

Cancer Res. 2012 Sep 15;72(18):4629-41. Epub 2012 Sep 7.

10.

Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression.

Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, Buart S, Berchem G, Romero P, Mami-Chouaib F, Chouaib S.

Cancer Res. 2011 Sep 15;71(18):5976-86. doi: 10.1158/0008-5472.CAN-11-1094. Epub 2011 Aug 2.

11.

The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis.

Noman MZ, Buart S, Van Pelt J, Richon C, Hasmim M, Leleu N, Suchorska WM, Jalil A, Lecluse Y, El Hage F, Giuliani M, Pichon C, Azzarone B, Mazure N, Romero P, Mami-Chouaib F, Chouaib S.

J Immunol. 2009 Mar 15;182(6):3510-21. doi: 10.4049/jimmunol.0800854.

12.

Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.

Mabrouk I, Buart S, Hasmim M, Michiels C, Connault E, Opolon P, Chiocchia G, Lévi-Strauss M, Chouaib S, Karray S.

Immunity. 2008 Dec 19;29(6):922-33. doi: 10.1016/j.immuni.2008.10.007. Epub 2008 Nov 13.

13.

Conditional, floxed allele of the Krox20 gene.

Taillebourg E, Buart S, Charnay P.

Genesis. 2002 Feb;32(2):112-3. No abstract available.

PMID:
11857793
14.

Hindbrain patterning: Krox20 couples segmentation and specification of regional identity.

Voiculescu O, Taillebourg E, Pujades C, Kress C, Buart S, Charnay P, Schneider-Maunoury S.

Development. 2001 Dec;128(24):4967-78.

15.

Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.

Lezin A, Buart S, Smadja D, Akaoka H, Bourdonné O, Perret-Liaudet A, Césaire R, Belin MF, Giraudon P.

AIDS Res Hum Retroviruses. 2000 Jul 1;16(10):965-72.

PMID:
10890358
18.

Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I).

Giraudon P, Buart S, Bernard A, Thomasset N, Belin MF.

Prog Neurobiol. 1996 Jun;49(2):169-84. Review.

PMID:
8844825

Supplemental Content

Support Center